Incannex starts screening patients in Phase 2 DReAMzz trial of IHL-42X for sleep apneaPUBT·Jul 23 at 06:32 AMIXHL-6.65%
Incannex Receives A$6.0M R&D Tax Refund, Expects A$11.1M+ in Non-Dilutive FundingTradingView·Jun 10 at 06:33 AMIXHL-6.65%
12 Health Care Stocks Moving In Monday's Intraday Sessionbenzinga_article·Jun 8 at 12:06 PMIXHL-6.65%TNGX-2.99%
Incannex Healthcare Inc. 1Q 2026: Revenue $0.09M, EPS $(0.35) — 10-Q SummaryTradingView·May 15 at 08:31 AMIXHL-6.65%IXJ+0.60%
Incannex Healthcare Officially Commences DReAMzz Clinical Study for IHL-42X in Obstructive Sleep Apnea | IXHL Stock NewsStockTitan·May 14 at 01:35 AMIXHL-6.65%XLV+0.70%
